Effects of exercise training together with tamoxifen in reducing mammary tumor burden in mice: Possible underlying pathway of miR-21

Eur J Pharmacol. 2015 Oct 15:765:179-87. doi: 10.1016/j.ejphar.2015.08.031. Epub 2015 Aug 20.

Abstract

Exercise training has an anti-tumor effect and can reduce tumor growth; however, the exact underlying mechanisms of its protective effects are still obscure. MicroRNA (miR)-21 is a predictor in cancer survival, and has a potential use as an indicator of therapeutic outcome in breast malignancies. Forty-eight female BALB/c mice were equally divided into six groups to investigate the effects of interval exercise training with tamoxifen on miR-21 expression and its possible assumed mechanisms in an estrogen receptor-positive breast cancer model. ELISA, immunohistochemistry, western blot, qRT-PCR assays were performed at the end of the study. Tumor size was significantly declined in exercise training and tamoxifen groups compared to tumor group (P<0.05). Expression of miR-21 was significantly down-regulated in trained and tamoxifen treated mice in comparison with tumor group (P<0.05). Exercise training was as effective as tamoxifen treatment in decreasing serum estradiol and ER-α expression (P<0.05). Exercise training and tamoxifen reduced tumor IL-6 levels, NF-kB and STAT3 expressions, and up-regulated TPM1 and PDCD4 expressions (P<0.05). Both exercise and tamoxifen had synergistic effects in reducing miR-21 and Bcl-2, and up-regulating PDCD4 expression. Results showed that interval exercise training may reduce mammary tumor burden in mice through possible underlying pathway of miR-21.

Keywords: Breast cancer; Interval exercise training; Tamoxifen; miR-21.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Biomarkers, Tumor / blood
  • Cell Line, Tumor
  • Combined Modality Therapy
  • Down-Regulation
  • Estradiol / blood
  • Female
  • Interleukin-6 / blood
  • Mammary Neoplasms, Experimental / drug therapy
  • Mammary Neoplasms, Experimental / genetics
  • Mammary Neoplasms, Experimental / pathology
  • Mammary Neoplasms, Experimental / therapy*
  • Mice, Inbred BALB C
  • MicroRNAs / genetics*
  • Physical Conditioning, Animal / physiology*
  • Tamoxifen / administration & dosage
  • Tamoxifen / therapeutic use*
  • Tumor Burden / drug effects*
  • Tumor Burden / genetics

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Interleukin-6
  • MIRN-21 microRNA, mouse
  • MicroRNAs
  • interleukin-6, mouse
  • Tamoxifen
  • Estradiol